← Leaderboards
Giulio Francesco Draetta
University Of Tx Md Anderson Can Ctr
$3,434,988
Attributed
$3,434,988
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $12.2M · FY2018–25$20M$15M$10M$5M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,203,756 · 4
By mechanism
P30$23,965,717 · 2
R01$1,819,638 · 1
P50$1,418,401 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Ronald Anthony Depinho$97,148,322
- Jennifer Keating Litton$5,442,418
- Michael W Andreeff$17,991,896
- George A. Calin$5,774,539
- Lynne V Abruzzo$2,251,267
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsCancer CenterUniversity Of Texas M D Anderson Cancer CenterTexasProgramsMissionGrantFutureAffectDesignTumorRecurrenceClinical TrialsLaboratoriesUniversitiesToxic EffectBiologyTranslatingCancer Center Support GrantResearch PersonnelResponseResistanceGeneticGenomics
Grant awards (23)
Leadership, Planning and Evaluation$101,498
P30 · FY2025 · CA · contact PI
Cancer Center Support Grant$18,709
P30 · FY2025 · CA · contact PI
Cancer Center Support Grant$11,270,944
P30 · FY2024 · CA · contact PI
Developing Automated tools for Cervical Cancer Radiotherapy Treatment for Zambian Women living with HIV (Biospecimen/Cohort)$231,771
P30 · FY2024 · CA · contact PI
CCSG Supplement: Early-Stage Surgeon Scientist (ESSP)$204,375
P30 · FY2024 · CA · contact PI
Cancer Center Support Grant$204,375
P30 · FY2024 · CA · contact PI
Cancer Center Support Grant$204,247
P30 · FY2024 · CA · contact PI
Leadership, Planning and Evaluation$95,451
P30 · FY2024 · CA · contact PI
Cancer Center Support Grant$11,029,670
P30 · FY2023 · CA · contact PI
Project 5: Targeting Oxidative Phosphorylation in AML$286,452
P50 · FY2023 · CA · contact PI
CCSG Supplement: Early-stage Surgeon Scientist Program (ESSP) - Chibawanye Ene$202,500
P30 · FY2023 · CA · contact PI
Cancer Center Support Grant$202,178
P30 · FY2023 · CA · contact PI
CCSG Supplement: Strengthen the Research, Training, and Outreach Capacity$199,999
P30 · FY2023 · CA · contact PI
Medium-chain acyl-coenzyme A dehydrogenase as an essential feeder of glioblastoma multiforme$357,311
R01 · FY2022 · CA · contact PI
Project 5: Targeting Oxidative Phosphorylation in AML$223,400
P50 · FY2022 · CA · contact PI
Medium-chain acyl-coenzyme A dehydrogenase as an essential feeder of glioblastoma multiforme$364,603
R01 · FY2021 · CA · contact PI
Project 5: Targeting Oxidative Phosphorylation in AML$223,400
P50 · FY2021 · CA · contact PI
Medium-chain acyl-coenzyme A dehydrogenase as an essential feeder of glioblastoma multiforme$364,603
R01 · FY2020 · CA · contact PI
Project 5: Targeting Oxidative Phosphorylation in AML$233,841
P50 · FY2020 · CA · contact PI
Medium-chain acyl-coenzyme A dehydrogenase as an essential feeder of glioblastoma multiforme$353,664
R01 · FY2019 · CA · contact PI
Project 5: Targeting Oxidative Phosphorylation in AML$236,193
P50 · FY2019 · CA · contact PI
Medium-chain acyl-coenzyme A dehydrogenase as an essential feeder of glioblastoma multiforme$379,457
R01 · FY2018 · CA · contact PI
Project 5: Targeting Oxidative Phosphorylation in AML$215,115
P50 · FY2018 · CA · contact PI